Drug shortages

Lisdexamfetamine Dimesylate Capsule

Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient

Current64850-552-01Psychiatry
Open FDA's page for this record
Update type
Reverified
Initial posting date
07/14/2023
Package NDC
64850-552-01
Generic name
Lisdexamfetamine Dimesylate Capsule
Contact info
888-852-6657
Availability
Limited Availability
Related info
Estimated recovery: TBD
Update date
11/17/2026
Dosage form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)
Company name
Elite Laboratories, Inc.
Shortage reason
Shortage of an active ingredient
Status
Current
Therapeutic category
Psychiatry
Harmonized identifiers (openFDA)
Application number
ANDA218604
Brand name
LISDEXAMFETAMINE DIMESYLATE
Generic name
LISDEXAMFETAMINE DIMESYLATE
Manufacturer name
Elite Laboratories, Inc.
Product NDC
64850-552, 64850-550, 64850-551, 64850-553, 64850-554, 64850-555, 64850-556
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
LISDEXAMFETAMINE DIMESYLATE
RxCUI
854830, 854834, 854838, 854842, 854846, 854850, 1593856
SPL ID
2d33f701-8067-4a48-98cc-4e7dacaf3cc4
SPL set ID
0e024b69-567c-4b40-9c3e-a2daec34256c
Package NDC
64850-550-01, 64850-551-01, 64850-552-01, 64850-553-01, 64850-554-01, 64850-555-01, 64850-556-01
UNII
SJT761GEGS
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.